Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research Participants

被引:126
作者
Gollust, S. E. [1 ]
Gordon, E. S. [2 ]
Zayac, C. [3 ]
Griffin, G. [3 ]
Christman, M. F. [2 ]
Pyeritz, R. E. [3 ,4 ]
Wawak, L. [2 ]
Bernhardt, B. A. [3 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA
[2] Coriell Inst Med Res, Camden, NJ USA
[3] Univ Penn, Penn Ctr Integrat Genet Healthcare Technol, Div Med Genet, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Commercialization; Consumer views; Genetic tests; Direct-to-consumer; Personalized medicine; Public expectations; Survey research; RISK; INFORMATION; GENETICS; PREVENTION; PROFILES; MEDICINE;
D O I
10.1159/000327296
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background/Aims: To predict the potential public health impact of personal genomics, empirical research on public perceptions of these services is needed. In this study, 'early adopters' of personal genomics were surveyed to assess their motivations, perceptions and intentions. Methods: Participants were recruited from everyone who registered to attend an enrollment event for the Coriell Personalized Medicine Collaborative, a United States-based (Camden, N.J.) research study of the utility of personalized medicine, between March 31, 2009 and April 1, 2010 (n = 369). Participants completed an Internet-based survey about their motivations, awareness of personalized medicine, perceptions of study risks and benefits, and intentions to share results with health care providers. Results: Respondents were motivated to participate for their own curiosity and to find out their disease risk to improve their health. Fewer than 10% expressed deterministic perspectives about genetic risk, but 32% had misperceptions about the research study or personal genomic testing. Most respondents perceived the study to have health-related benefits. Nearly all (92%) intended to share their results with physicians, primarily to request specific medical recommendations. Conclusion: Early adopters of personal genomics are prospectively enthusiastic about using genomic profiling information to improve their health, in close consultation with their physicians. This suggests that early users (i.e. through direct-to-consumer companies or research) may follow up with the health care system. Further research should address whether intentions to seek care match actual behaviors. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:22 / 30
页数:9
相关论文
共 38 条
[1]   Participation in Genetic Testing Research Varies by Social Group [J].
Alford, Sharon Hensley ;
McBride, Colleen M. ;
Reid, Robert J. ;
Larson, Eric B. ;
Baxevanis, Andreas D. ;
Brody, Lawrence C. .
PUBLIC HEALTH GENOMICS, 2011, 14 (02) :85-93
[2]   Disseminating innovations in health care [J].
Berwick, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (15) :1969-1975
[3]   Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk. [J].
Bloss, Cinnamon S. ;
Schork, Nicholas J. ;
Topol, Eric J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :524-534
[4]   Consumer perceptions of direct-to-consumer personalized genomic risk assessments [J].
Bloss, Cinnamon S. ;
Ornowski, Laura ;
Silver, Elana ;
Cargill, Michele ;
Vanier, Vance ;
Schork, Nicholas J. ;
Topol, Eric J. .
GENETICS IN MEDICINE, 2010, 12 (09) :556-566
[5]   Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes European Society of Human Genetics [J].
Borry, P. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (12) :1271-1273
[6]   Personalized medicine in the era of genomics [J].
Burke, Wylie ;
Psaty, Bruce M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (14) :1682-1684
[7]   Direct-to-consumer genetic testing: good, bad or benign? [J].
Caulfield, T. ;
Ries, N. M. ;
Ray, P. N. ;
Shuman, C. ;
Wilson, B. .
CLINICAL GENETICS, 2010, 77 (02) :101-105
[8]   Public understandings of genetics and health [J].
Condit, C. M. .
CLINICAL GENETICS, 2010, 77 (01) :1-9
[9]   Bioethical and Clinical Dilemmas of Direct-to-Consumer Personal Genomic Testing: The Problem of Misattributed Equivalence [J].
Eng, Charis ;
Sharp, Richard R. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (17)
[10]   Direct to consumer genetic testing: Avoiding a culture war [J].
Evans, James P. ;
Green, Robert C. .
GENETICS IN MEDICINE, 2009, 11 (08) :568-569